TipRanks
AegirBio AB (SE:SUBGEN)
:SUBGEN
Sweden Market
SUBGEN
AegirBio AB
RESEARCH TOOLSreports
Want to see SE:SUBGEN full AI Analyst Report?

AegirBio AB (SUBGEN) Income Statement

1 Followers

AegirBio AB Income Statement

Last quarter (Q2 2026), AegirBio AB's total revenue was kr61.96M, a decrease of -252.79% from the same quarter last year. In Q2, AegirBio AB's net income was kr-19.30M. See AegirBio AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 204.39Mkr 203.76Mkr 92.00Kkr 1.71Mkr 13.28M
Gross Profit
kr 75.16Mkr -14.27Mkr 44.00Kkr -23.71Mkr 5.51M
Operating Expenses
kr 204.37Mkr 22.27Mkr 56.20Mkr 341.39Mkr 85.67M
Depreciation and Amortization
kr 24.57Mkr 14.27Mkr 16.52Mkr 12.31Mkr 7.99M
EBITDA
kr -104.63Mkr -27.02Mkr -34.67Mkr -351.78Mkr -74.20M
Operating Income
kr -129.21Mkr -36.55Mkr -56.16Mkr -91.48Mkr -83.76M
Other Income/Expenses
kr 39.21Mkr -14.97Mkr -5.03Mkr -272.83Mkr -8.90M
Pretax Income
kr -90.00Mkr -51.52Mkr -61.19Mkr -364.31Mkr -92.66M
Net Income
kr -88.88Mkr -49.63Mkr -59.70Mkr -362.83Mkr -92.33M
Per Share Metrics
Basic EPS
kr -0.41kr -161.05kr -2.38kr -18.90kr -5.64
Diluted EPS
kr -567.45kr -161.05kr -2.38kr -18.90kr -5.64
Weighted Average Shares Outstanding
 154.58K 308.18K 25.05M 19.20M 16.38M
Weighted Average Shares Outstanding (Diluted)
 154.58K 308.18K 25.05M 19.20M 16.38M
Currency in SEK

AegirBio AB Earnings and Revenue History